Trials / Completed
CompletedNCT00599339
Transdermal Rotigotine User Surveillance Study
A Naturalistic, Multisite, Observational Study of Rotigotine Transdermal Patch and Other Currently Prescribed Therapies in Patients With Idiopathic Parkinson's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,195 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will be conducted in an observational multiple-cohort design aimed at acquiring clinical, treatment, health status, and economic data. Patients with Parkinson's disease (PD) will be enrolled.
Detailed description
All patients attending the physician and fulfilling the eligibility criteria are included.
Conditions
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2008-01-23
- Last updated
- 2018-08-09
- Results posted
- 2015-04-29
Locations
211 sites across 10 countries: Czechia, Denmark, Germany, Greece, Italy, Mexico, Romania, Slovakia, Spain, Switzerland
Source: ClinicalTrials.gov record NCT00599339. Inclusion in this directory is not an endorsement.